172 related articles for article (PubMed ID: 36580018)
41. HLA-A*26 and susceptility of iranian patients with non-Hodgkin lymphoma.
Sayad A; Akbari MT; Mehdizadeh M; Taheri M; Hajifathali A
Iran J Immunol; 2014 Dec; 11(4):269-74. PubMed ID: 25549594
[TBL] [Abstract][Full Text] [Related]
42. Association between matrix metalloproteinase 2 (MMP2) promoter polymorphisms and the susceptibility to non-Hodgkin's lymphoma in Egyptians.
Gouda HM; Khorshied MM; El Sissy MH; Shaheen IA; Mohsen MM
Ann Hematol; 2014 Aug; 93(8):1313-8. PubMed ID: 24627195
[TBL] [Abstract][Full Text] [Related]
43. Association of Caspase-8 Genotypes With Oral Cancer Risk in Taiwan.
Shih LC; Tsai CW; Sun KT; Hsu HM; Shen TC; Tsai YT; Chang WS; Lin ML; Wang YC; Gong CL; Bau DT
In Vivo; 2019; 33(4):1151-1156. PubMed ID: 31280204
[TBL] [Abstract][Full Text] [Related]
44. [Association of XRCC1 genetic polymorphism with susceptibility to non-Hodgkin's lymphoma].
Li SX; Zhu HL; Guo B; Yang Y; Wang HY; Sun JF; Cao YB
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Aug; 22(4):982-7. PubMed ID: 25130814
[TBL] [Abstract][Full Text] [Related]
45. The relationship of CASP 8 polymorphism and cancer susceptibility: a meta-analysis.
Ji GH; Li M; Cui Y; Wang JF
Cell Mol Biol (Noisy-le-grand); 2014 Dec; 60(6):20-8. PubMed ID: 25553350
[TBL] [Abstract][Full Text] [Related]
46. Association Study of the Caspase Gene Family and Psoriasis Vulgaris Susceptibility in Northeastern China.
Yao X; Hao S; Yu P
Biomed Res Int; 2019; 2019():2417612. PubMed ID: 30906769
[TBL] [Abstract][Full Text] [Related]
47. Polymorphisms in innate immunity genes and risk of non-Hodgkin lymphoma.
Forrest MS; Skibola CF; Lightfoot TJ; Bracci PM; Willett EV; Smith MT; Holly EA; Roman E
Br J Haematol; 2006 Jul; 134(2):180-3. PubMed ID: 16740140
[TBL] [Abstract][Full Text] [Related]
48. Influence of caspases 8 and 9 gene promoter polymorphism on prostate cancer susceptibility and early development of hormone refractory prostate cancer.
Kesarwani P; Mandal RK; Maheshwari R; Mittal RD
BJU Int; 2011 Feb; 107(3):471-6. PubMed ID: 20804486
[TBL] [Abstract][Full Text] [Related]
49. Role of polymorphisms in BCL-2 and BAX genes in modulating the risk of developing non-Hodgkin lymphoma.
Wang WL; Tao YP; Han XL; Li X; Zi YM; Yang C; Li JD
Leuk Lymphoma; 2014 Jul; 55(7):1602-8. PubMed ID: 24024471
[TBL] [Abstract][Full Text] [Related]
50. Interleukin 2 gene polymorphisms are associated with non-Hodgkin lymphoma.
Song H; Chen L; Cha Z; Bai J
DNA Cell Biol; 2012 Jul; 31(7):1279-84. PubMed ID: 22472080
[TBL] [Abstract][Full Text] [Related]
51. HLA-G Gene Polymorphism in Egyptian Patients with Non-Hodgkin Lymphoma and its Clinical Outcome.
Tawfeek GA; Alhassanin S
Immunol Invest; 2018 Apr; 47(3):315-325. PubMed ID: 29388862
[TBL] [Abstract][Full Text] [Related]
52. Polymorphisms in the promoter region of the CASP8 gene are not associated with non-Hodgkin's lymphoma in Chinese patients.
Xiao MS; Zhang DF; Zeng Y; Cheng YF; Yao YG
Ann Hematol; 2011 Oct; 90(10):1137-44. PubMed ID: 21633787
[TBL] [Abstract][Full Text] [Related]
53. Single-nucleotide polymorphisms in genes encoding for CC chemokines were not associated with the risk of non-Hodgkin lymphoma.
Chen Q; Zheng T; Lan Q; Lerro C; Zhao N; Qin Q; Hu X; Huang H; Liang J; Holford T; Leaderer B; Boyle P; Chanock SJ; Rothman N; Zhang Y
Cancer Epidemiol Biomarkers Prev; 2013 Jul; 22(7):1332-5. PubMed ID: 23640258
[TBL] [Abstract][Full Text] [Related]
54. Relationship between interferon regulatory factor 4 genetic polymorphisms, measures of sun sensitivity and risk for non-Hodgkin lymphoma.
Gathany AH; Hartge P; Davis S; Cerhan JR; Severson RK; Cozen W; Rothman N; Chanock SJ; Wang SS
Cancer Causes Control; 2009 Oct; 20(8):1291-302. PubMed ID: 19396635
[TBL] [Abstract][Full Text] [Related]
55. CASP9 c.-1339A>G and CASP3 c.-1191A>G polymorphisms alter susceptibility and clinical aspects of head and neck squamous cell carcinoma.
Costa EFD; Lopes-Aguiar L; Nogueira GS; Lima TRP; Rinck-Junior JA; Lourenço GJ; Lima CSP
Head Neck; 2019 Aug; 41(8):2665-2670. PubMed ID: 30903678
[TBL] [Abstract][Full Text] [Related]
56. Polymorphisms in DNA repair genes and risk of non-Hodgkin lymphoma in a pooled analysis of three studies.
Shen M; Menashe I; Morton LM; Zhang Y; Armstrong B; Wang SS; Lan Q; Hartge P; Purdue MP; Cerhan JR; Grulich A; Cozen W; Yeager M; Holford TR; Vajdic CM; Davis S; Leaderer B; Kricker A; Severson RK; Zahm SH; Chatterjee N; Rothman N; Chanock SJ; Zheng T
Br J Haematol; 2010 Nov; 151(3):239-44. PubMed ID: 20813000
[TBL] [Abstract][Full Text] [Related]
57. A functional polymorphism in microRNA-196a2 is associated with increased susceptibility to non-Hodgkin lymphoma.
Li T; Niu L; Wu L; Gao X; Li M; Liu W; Yang L; Liu D
Tumour Biol; 2015 May; 36(5):3279-84. PubMed ID: 25501512
[TBL] [Abstract][Full Text] [Related]
58. Genetic Susceptibility in Acute Pancreatitis: Genotyping of GSTM1, GSTT1, GSTP1, CASP7, CASP8, CASP9, CASP10, LTA, TNFRSF1B, and TP53 Gene Variants.
Dʼ Oliveira Martins F; Gomes BC; Rodrigues AS; Rueff J
Pancreas; 2017 Jan; 46(1):71-76. PubMed ID: 27984487
[TBL] [Abstract][Full Text] [Related]
59. Immune mechanisms in non-Hodgkin lymphoma: joint effects of the TNF G308A and IL10 T3575A polymorphisms with non-Hodgkin lymphoma risk factors.
Wang SS; Cozen W; Cerhan JR; Colt JS; Morton LM; Engels EA; Davis S; Severson RK; Rothman N; Chanock SJ; Hartge P
Cancer Res; 2007 May; 67(10):5042-54. PubMed ID: 17510437
[TBL] [Abstract][Full Text] [Related]
60. Genetic variation in Th1/Th2 pathway genes and risk of non-Hodgkin lymphoma: a pooled analysis of three population-based case-control studies.
Lan Q; Wang SS; Menashe I; Armstrong B; Zhang Y; Hartge P; Purdue MP; Holford TR; Morton LM; Kricker A; Cerhan JR; Grulich A; Cozen W; Zahm SH; Yeager M; Vajdic CM; Schenk M; Leaderer B; Yuenger J; Severson RK; Chatterjee N; Chanock SJ; Zheng T; Rothman N
Br J Haematol; 2011 May; 153(3):341-50. PubMed ID: 21418175
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
